Grifols - GRFS Net Assets per Single Share

Graphic logo of Grifols, S.A. (GRFS)

The market price for Grifols, S.A. (GRFS) on the GURU.Markets platform, as confirmed by the chart, is 9.36. Grifols, S.A. (GRFS) dominates the plasma derivatives segment, where colossal expenditures on plants and regulatory oversight create insurmountable barriers to entry for new players. Business resilience relies on donation volumes and the stringency of sanitary standards. Currently, the R&D center is optimizing expenses, focusing on Alzheimer's research and protein isolation methods.

Grifols SA (GRFS): Share Book Value from 07/04/2022 to 10/27/2026

grifols.com - analytical breakdowns and key metrics (GRFS)

- price and consensus price forecast:
Stock Price Grifols Group|GRFS - Forecast Levels Chart
- market capitalization data:
Market Value Grifols, S.A.|GRFS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Grifols|GRFS - Net Asset Value|Market Capitalization to Book Value Ratio grifols.com|GRFS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Grifols, S.A.|GRFS - Long-Term Debt to Capital|Short-Term Debt to Equity Grifols|GRFS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Grifols, S.A.
Fundamental company valuation:Grifols Group - GRFS
Manufactured products of Grifols

Assessing asset quality requires an analysis of the residual value of capital minus liabilities. This metric measures the internal balance sheet reserve available to each shareholder upon business liquidation. The trend in net asset value per share reflects the actual stability of the financial foundation. For Grifols, S.A. (GRFS), growth in this value would confirm the success of deleveraging and the efficiency of commercializing new immunoglobulins. The recovery of asset value will serve as a key indicator of returning market confidence.

Competitors of Grifols, S.A. (GRFS)

Book Value per Share Argenx|BNTX: Share Book Value|Abivax Corp - Net Assets per Single Share|ADMA (admabiologics.com) - Net Assets per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Adaptive Biotechnologies Inc. (ADPT)|Book Value per Share CLDX (Celldex Therapeutics)|auriniapharma.com - Book Value per Share|Net Assets per Single Share BioCryst Pharmaceuticals (BCRX)|VERA: Accounting Value of a Share|DNTH (Dianthus Pharma) - Net Assets per Single Share|Pharvaris Pharma (PHVS) - Accounting Value per Share|ABCL (AbCellera Biologics Inc) - Book Value per Share|Book Value per Share tourmalinebio.com (TRML)|Precigen (PGEN) - Accounting Value per Share|Accounting Value of a Share Pharming Group NV (PHAR)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|Book Value per Share ENGN|RAPT: Book Value of One Share|Net Assets per Single Share aerovatetx.com JBIO|aclaristx.com (ACRS) - Accounting Value of a Share|KYTX: Book Value per Share|Net Assets per Share Tiziana Life Sciences Ltd.|CABA - Book Value per Share|Share Book Value VTYX (Ventyx Biosciences, Inc)|THTX: Net Assets per Single Share|avalotx.com - Net Asset Value per Share|ELDN - Net Assets per Single Share|AGEN: Net Assets per Single Share|Climb Bio, Inc. - Net Assets per Single Share|Net Assets per Share Zura Bio Ltd|ATYR - Accounting Value per Share|Accounting Value of a Share ADAG|IMA (ImageneBio Inc) - Net Assets per Single Share|Net Assets per Share shattucklabs.com STTK|Accounting Value per Share EQ|Net Assets per Share Connect Biopharma Holdings CNTB|Immunic Inc - Book Value per Share|Atara Biotherapeutics (ATRA) - Book Value per Share|inflarx.de - Accounting Value per Share|X4 Pharmaceuticals Inc. (XFOR) - Net Assets per Share|Adicet Bio Inc. - Book Value per Share|Book Value of One Share CELU|INmune Bio, Inc. (INMB) - Net Assets per Single Share|Accounting Value of a Share barinthusbio.com (BRNS)|Kezar Life Sciences, Inc. (KZR) - Book Value per Share|SAB Biotherapeutics Inc. - Share Book Value|Net Assets per Single Share AKTX (Akari Therapeutics plc)|ENLV: Net Assets per Share|Net Assets per Single Share q32bio.com (QTTB)|geovax.com (GOVX) - Share Book Value|EDSA - Book Value per Share|Accounting Value of a Share iBio Inc|Book Value per Share CARM|Book Value per Share XTLB (XTL Bio)|Net Assets per Single Share Bolt Biotherapeutics, Inc.|HCW Biologics, Inc. - Accounting Value of a Share|APVO: Net Assets per Single Share|AIM - Accounting Value per Share|ADTX: Book Value per Share|Book Value per Share GRI Bio Corporation|XRTX - Accounting Value per Share|Accounting Value of a Share reshapelifesciences.com|REVB (Revelation Biosciences, Inc.) - Book Value per Share|Net Assets per Share INDP (Indaptus Therapeutics Inc)|Scinai - Net Assets per Single Share|CalciMedica Inc - Accounting Value per Share|AFMD: Net Assets per Single Share|Allakos Inc. (ALLK) - Accounting Value per Share|HOOK: Accounting Value per Share|IGMS (IGM Biosciences) - Book Value per Share|Net Assets per Single Share iTeos (ITOS)|Equity per Share Ocean Biomedical Corp|TC Biopharm - Book Value per Share|Net Asset Value per Share thirdharmonicbio.com (THRD)